Level Chart

Basic Info

Johnson & Johnson (JNJ) - Pharmaceutical Revenue is at a current level of 13.89B, up from 13.73B last quarter and up from 13.32B one year ago. This is a change of 1.18% from last quarter and 4.33% from one year ago.

Pharmaceutical Revenue refers to the total revenue generated by Johnson & Johnson from its pharmaceutical segment.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 13.89B
Latest Period Oct 2023
Last Updated Jan 12 2024, 16:52 EST
Average Growth Rate 7.84%
Value from Last Quarter 13.73B
Change from Last Quarter 1.18%
Value from 1 Year Ago 13.32B
Change from 1 Year Ago 4.33%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
October 01, 2023 13.89B
July 02, 2023 13.73B
March 31, 2023 13.41B
January 01, 2023 13.16B
October 02, 2022 13.21B
July 03, 2022 13.32B
April 03, 2022 12.87B
January 02, 2022 14.22B
Date Value
October 03, 2021 12.88B
July 04, 2021 12.48B
April 04, 2021 12.10B
January 03, 2021 12.27B
September 27, 2020 11.42B
June 28, 2020 10.75B
March 29, 2020 11.13B
December 29, 2019 10.55B

Basic Info

Johnson & Johnson (JNJ) - Pharmaceutical Revenue is at a current level of 13.89B, up from 13.73B last quarter and up from 13.32B one year ago. This is a change of 1.18% from last quarter and 4.33% from one year ago.

Pharmaceutical Revenue refers to the total revenue generated by Johnson & Johnson from its pharmaceutical segment.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 13.89B
Latest Period Oct 2023
Last Updated Jan 12 2024, 16:52 EST
Average Growth Rate 7.84%
Value from Last Quarter 13.73B
Change from Last Quarter 1.18%
Value from 1 Year Ago 13.32B
Change from 1 Year Ago 4.33%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
JNJ Johnson & Johnson -0.46%